Yuri van der Burgt0000-0003-0556-5564
Yuri van der Burgt was born in 1971. He obtained his Ph.D. degree in bioorganic chemistry at Utrecht University, Utrecht, Netherlands, in 1999. During his Ph.D. studies, he worked on the structural analysis of biomolecules, carbohydrates in specific, using various high-end analytical techniques such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. In his postdoctoral work, he focused on MS and proteomics at the Leiden University Medical Center (LUMC), Leiden, Netherlands. At the Department of Parasitology, he contributed to the establishment of a glycoproteomics facility with the introduction of nanoflow liquid chromatography (LC) coupled to ion trap MS. From 2002 to 2005, he worked as a Scientist at the biotechnology company Crucell, where he was responsible for the (mass spectrometric) analysis of recombinant proteins. Additionally, he developed new methods to monitor adenovector stability and coordinated stability studies in the preclinical vaccine programs. To follow his ambitions in clinical research and strengthen his expertise in the field of biomolecular MS, he then moved to the FOM Institute in Amsterdam to work on biomarker discovery within the Netherlands Proteomics Centre (NPC). He developed data processing and analysis strategies in collaboration with the Netherlands Bioinformatics Centre (NBIC). Currently, he works as an Associate Professor at the LUMC and is responsible for multiple MS platforms that are applied for both in-depth analyses and high-throughput clinical proteomics and profiling studies.
Biography Updated on 15 January 2015